Literature DB >> 27011493

Neoangiogenesis. Assessment in Esophageal Adenocarcinomas.

Valeriu Ardeleanu1, Laurian Francu2, Costinela Georgescu1.   

Abstract

Esophageal cancer has always been subject of research for various studies. According to some authors, esophageal cancer represents the 10th leading cause of cancer in the world with a 5-year survival of 10 %. In terms of anatomopathological form of the esophageal neoplasia, the literature mainly describes two major pathological types: adenocarcinoma and esophageal squamous cell carcinoma. Lately there has been an increased incidence of esophageal adenocarcinoma. The aim of the present work was to study neoangiogenesis in esophageal adenocarcinomas. The study was conducted on 40 cases diagnosed and surgically treated. Subsequently, fragment processing was performed using various immunohistochemical staining and marking with CD34 and p53 antigen. Later, quantitative measurements were performed, and images were taken using a microscope imaging system. In the end of the procedures, the professional program PRODIT 5.2. was applied. The study of the vascular system in the esophageal epithelial tumors revealed an axis consisting of three elements which have a mutual induction process: inflammatory infiltrate-neoangiogenesis-fibrosis, with significant differences between the three degrees of differentiation. A significant increase in tumor micro vascular density was present together with the increasing of the histological grading, with an inverse correlation with the degree of differentiation and directly proportional to the risk of malignancy.

Entities:  

Keywords:  Esophagus; Neoangiogenesis; Quantitative; Tumor

Year:  2014        PMID: 27011493      PMCID: PMC4775699          DOI: 10.1007/s12262-014-1091-9

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  19 in total

1.  p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.

Authors:  Y S Bian; M C Osterheld; F T Bosman; J Benhattar; C Fontolliet
Journal:  Mod Pathol       Date:  2001-05       Impact factor: 7.842

2.  Outcomes after esophagectomy in patients with prior antireflux or hiatal hernia surgery.

Authors:  Andrew C Chang; Julia S Lee; Konrad T Sawicki; Allan Pickens; Mark B Orringer
Journal:  Ann Thorac Surg       Date:  2010-04       Impact factor: 4.330

Review 3.  The p53 pathway: positive and negative feedback loops.

Authors:  Sandra L Harris; Arnold J Levine
Journal:  Oncogene       Date:  2005-04-18       Impact factor: 9.867

4.  Interactions between environmental factors and polymorphisms in angiogenesis pathway genes in esophageal adenocarcinoma risk: a case-only study.

Authors:  Rihong Zhai; Yang Zhao; Geoffrey Liu; Monica Ter-Minassian; I-Chen Wu; Zhaoxi Wang; Li Su; Kofi Asomaning; Feng Chen; Matthew H Kulke; Xihong Lin; Rebecca S Heist; John C Wain; David C Christiani
Journal:  Cancer       Date:  2011-07-12       Impact factor: 6.860

5.  p53 in esophageal adenocarcinoma: a critical reassessment of mutation frequency and identification of 72Arg as the dominant allele.

Authors:  Sun M Chung; Jean Kao; Elizabeth Hyjek; Yao-Tseng Chen
Journal:  Int J Oncol       Date:  2007-12       Impact factor: 5.650

Review 6.  Fibroblasts in cancer.

Authors:  Raghu Kalluri; Michael Zeisberg
Journal:  Nat Rev Cancer       Date:  2006-05       Impact factor: 60.716

7.  c-MET as a potential therapeutic target and biomarker in cancer.

Authors:  J Rafael Sierra; Ming-Sound Tsao
Journal:  Ther Adv Med Oncol       Date:  2011-11       Impact factor: 8.168

8.  Vascular endothelial growth factor (VEGF) stimulates monocyte migration through endothelial monolayers via increased integrin expression.

Authors:  M Heil; M Clauss; K Suzuki; I R Buschmann; A Willuweit; S Fischer; W Schaper
Journal:  Eur J Cell Biol       Date:  2000-11       Impact factor: 4.492

9.  Hepatocellular carcinoma-fibrolamellar variant: cytopathology of an unusual case.

Authors:  George Kunz; Jeffrey Chung; Syed Z Ali
Journal:  Diagn Cytopathol       Date:  2002-04       Impact factor: 1.582

Review 10.  The P53 pathway: what questions remain to be explored?

Authors:  A J Levine; W Hu; Z Feng
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

View more
  3 in total

1.  Overexpression of Survivin-1, TAG-72 and HERC5 in patients diagnosed with hepatocellular carcinoma in the Black Sea coast geographical area.

Authors:  Andra-Iulia Suceveanu; Ioan Sergiu Micu; Gabriela-Izabela Baltatescu; Lucian Cristian Petcu; Nicolae Dobrin; Costel Brinzan; Cornelia Nitipir; Laura Mazilu; Florin Botea; Vlad Herlea; Felix Voinea; Adrian Paul Suceveanu
Journal:  Exp Ther Med       Date:  2021-01-26       Impact factor: 2.447

2.  Acute surgical abdomen during the COVID-19 pandemic: Clinical and therapeutic challenges.

Authors:  Dragos Serban; Bogdan Socea; Cristinel Dumitru Badiu; Corneliu Tudor; Simona Andreea Balasescu; Dan Dumitrescu; Andra Maria Trotea; Radu Iulian Spataru; Geta Vancea; Ana Maria Dascalu; Ciprian Tanasescu
Journal:  Exp Ther Med       Date:  2021-03-22       Impact factor: 2.447

Review 3.  Gadolinium-based contrast agents in neurofibromatosis type 1 (Review).

Authors:  Florentina Năstase; Diana Sabina Radaschin; Elena Niculeț; Bogdan Ioan Stefanescu; Aurel Nechita; Draganescu Miruna; Liliana Baroiu; Arbune Manuela; Alin Laurenţiu Tatu
Journal:  Exp Ther Med       Date:  2021-03-23       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.